Babicheva Aleksandra, Elmadbouh Ibrahim, Song Shanshan, Thompson Michael A, Powers Ryan, Jain Pritesh P, Izadi Amin, Chen Jiyuan, Yung Lauren, Parmisano Sophia, Paquin Cole, Wang Wei-Ting, Chen Yuqin, Wang Ting, Alotaibi Mona, Shyy John Y-J, Thistlethwaite Patricia A, Wang Jian, Makino Ayako, Prakash Y S, Pabelick Christina M, Yuan Jason X-J
The Hormel Institute, University of Minnesota, Austin, Minnesota, United States.
Lillehei Heart Institute, School of Medicine, University of Minnesota, Minneapolis, Minnesota, United States.
Am J Physiol Lung Cell Mol Physiol. 2025 Jun 1;328(6):L844-L857. doi: 10.1152/ajplung.00400.2024. Epub 2025 May 7.
Endothelial-to-mesenchymal transition (EndMT) is a biological process that converts endothelial cells to mesenchymal cells with increased proliferative and migrative abilities. EndMT has been implicated in the development of pulmonary vascular remodeling in pulmonary arterial hypertension (PAH), a fatal and progressive lung vascular disease. Transforming growth factor β (TGF-β), an inflammatory cytokine, is known to induce EndMT in many types of endothelial cells including lung vascular endothelial cells (LVECs). An increase in cytosolic free Ca concentration ([Ca]) is a major stimulus for cellular proliferation and phenotypic transition, but it is unknown whether Ca signaling is involved in EndMT. In this study, we tested the hypothesis that TGF-β-induced EndMT in human LVEC is Ca-dependent. Treatment of LVEC with TGF-β for 5-7 days resulted in increase in SNAI1/2 expression, induction of EndMT, upregulation of STIM/Orai1, and enhancement of store-operated Ca entry (SOCE). Removal (or chelation) of extracellular or intracellular Ca with EGTA or BAPTA-AM, respectively, abolished EndMT in response to TGF-β. Moreover, EGTA diminished TGF-β-induced increase in SNAI in a dose-dependent manner. Knockdown of either STIM1 or Orai1 was sufficient to prevent TGF-β-mediated increase in SNAI1/2 and EndMT but did not rescue the continuous adherent junctions. Blockade of Orai1 channels by AnCoA4 inhibited TGF-β-mediated EndMT and restored PECAM1-positive continuous adherent junctions. In conclusion, intracellular Ca signaling plays a critical role in TGF-β-associated EndMT through enhanced SOCE and STIM1-Orai1 interaction. Thus, targeting Ca signaling pathways regulating EndMT may be a novel therapeutic approach to treat PAH and other forms of precapillary pulmonary hypertension. EndMT has been reported to contribute to the pathogenesis of PAH. In this study, we aimed to determine the role of Ca signaling in the development of EndMT in human lung vascular endothelial cells. Our data suggest that TGF-β requires store-operated Ca entry through STIM1/Orai channels to induce SNAI-mediated EndMT. For the first time, we demonstrated that TGF-β-induced EndMT is a Ca-dependent event, whereas inhibition of STIM1/Orai interaction attenuated EndMT in response to TGF-β.
内皮-间充质转化(EndMT)是一个生物学过程,它将内皮细胞转化为具有更强增殖和迁移能力的间充质细胞。EndMT与肺动脉高压(PAH,一种致命的进行性肺血管疾病)中肺血管重塑的发展有关。转化生长因子β(TGF-β)是一种炎症细胞因子,已知它能在包括肺血管内皮细胞(LVECs)在内的多种类型内皮细胞中诱导EndMT。胞质游离钙浓度([Ca])的增加是细胞增殖和表型转变的主要刺激因素,但尚不清楚钙信号是否参与EndMT。在本研究中,我们检验了TGF-β诱导人LVEC发生EndMT是依赖钙的这一假说。用TGF-β处理LVEC 5至7天导致SNAI1/2表达增加、EndMT诱导、STIM/Orai1上调以及储存-操作性钙内流(SOCE)增强。分别用EGTA或BAPTA-AM去除(或螯合)细胞外或细胞内钙,可消除对TGF-β的EndMT反应。此外,EGTA以剂量依赖方式减少TGF-β诱导的SNAI增加。敲低STIM1或Orai1足以阻止TGF-β介导的SNAI1/2增加和EndMT,但不能挽救连续的黏附连接。AnCoA4对Orai1通道的阻断抑制了TGF-β介导的EndMT并恢复了PECAM1阳性的连续黏附连接。总之,细胞内钙信号通过增强SOCE和STIM1-Orai1相互作用在TGF-β相关的EndMT中起关键作用。因此,靶向调节EndMT的钙信号通路可能是治疗PAH和其他形式的毛细血管前性肺动脉高压的一种新的治疗方法。EndMT已被报道与PAH的发病机制有关。在本研究中,我们旨在确定钙信号在人肺血管内皮细胞EndMT发展中的作用。我们的数据表明,TGF-β需要通过STIM1/Orai通道的储存-操作性钙内流来诱导SNAI介导的EndMT。我们首次证明,TGF-β诱导的EndMT是一个依赖钙的事件,而抑制STIM1/Orai相互作用可减弱对TGF-β的EndMT反应。